Have a personal or library account? Click to login
Cephalosporin-induced hemolytic anemia: a case study Cover

Cephalosporin-induced hemolytic anemia: a case study

Immunohematology
Volume 41 (2025): Issue 4 (December 2025)
By: Graça Almeida,  Ana Costa and  Eugénia Vasconcelos  
Paid access
|Dec 2025

Authors

Graça Almeida

graca.almeida@ipst.min-saude.pt

Reference Laboratory of Immunohematology, Portuguese Institute of Blood and Transplantation, IPST, IP, Lisbon, Portugal

Ana Costa

Immunohemotherapy and Transfusional Medicine–Hemovida, Hospital Beatriz Ângelo, Lisbon, Portugal

Eugénia Vasconcelos

Immunohemotherapy and Transfusional Medicine, IPST, IP, Lisbon, Portugal
DOI: https://doi.org/10.2478/immunohematology-2025-016 | Journal eISSN: 1930-3955 | Journal ISSN: 0894-203X
Journal RSS Feed
Language: English
Page range: 111 - 116
Published on: Dec 31, 2025
Published by: American National Red Cross
In partnership with: Paradigm Publishing Services
Publication frequency: 4 issues per year
Keywords:
DIIHA,
cefuroxime,
ceftriaxone,
drug-dependent antibodies,
immune hemolytic anemia
Related subjects:
Medicine,
Clinical medicine,
Laboratory medicine

© 2025 Graça Almeida, Ana Costa, Eugénia Vasconcelos, published by American National Red Cross
This work is licensed under the Creative Commons License.

Previous articleVolume 41 (2025): Issue 4 (December 2025)Next article